Management of hyperlipidemia with statins in the older patient

References

• AronowWS2004Don’t trust an LDL over 70? New data requires revising NCEP III guidelines for middle-age and older adultsGeriatrics59121315152729
   PubMed Web of Science ®Google Scholar
• AronowWSAhnC2002aFrequency of congestive heart failure in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dl treated with statins versus no lipid-lowering drugAm J Cardiol901479
   PubMed Web of Science ®Google Scholar
• AronowWSAhnC2002bIncidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statins versus no lipid-lowering drugAm J Cardiol89679
   PubMed Web of Science ®Google Scholar
• AronowWSAhnC2002cReduction of coronary events with aspirin in older patients with prior myocardial infarction treated with and without statinsHeart Dis415961
   Google Scholar
• AronowWSAhnC2002dFrequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol ≥125 mg/dl treated with statins versus no lipid-lowering drugAm J Cardiol9078991
   PubMed Web of Science ®Google Scholar
• AronowWSAhnCGutsteinH2002aIncidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statins versus no lipid-lowering drugJ Gerontol Med Sci57AM3335
   Web of Science ®Google Scholar
• AronowWSAhnCGutsteinH2002bReduction of new coronary events and of new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statinsJ Gerontol Med Sci57AM74750
   Web of Science ®Google Scholar
• AronowWSAhnCKronzonI2001Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older personsAm J Cardiol88693511564402
   PubMed Web of Science ®Google Scholar
• AronowWSNayakDWoodworthS2003Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatmentAm J Cardiol927111212972114
   PubMed Web of Science ®Google Scholar
• BellamyMFPellikkaTAKlarichKW2002Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the communityJ Am Coll Cardiol4017233012446053
   PubMed Web of Science ®Google Scholar
• CalhounHMBetteridgeDJDurringtonPN2004Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes mellitus in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomized placebo-controlled trialLancet3646859615325833
   PubMed Web of Science ®Google Scholar
• CannonCPBraunwaldEMcCabeCH2004Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromesN Engl J Med350149550415007110
   PubMed Web of Science ®Google Scholar
• [CTT] Cholesterol Treatment Trialists’ (CTT) Collaborators2005Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsLancet36612677816214597
   PubMed Web of Science ®Google Scholar
• de LemosJABlazingMAWiviottSD2004Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trialJAMA29213071615337732
   PubMed Web of Science ®Google Scholar
• FoodyJMShahRGalushaD2006Statins and mortality among elderly patients hospitalized with heart failureCirculation11310869216490817
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIMerzCNB2004Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesCirculation1102273915249516
   PubMed Web of Science ®Google Scholar
• [HPS] Heart Protection Study Collaborative Group2002MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trialLancet36072212114036
   PubMed Web of Science ®Google Scholar
• HorwichTBMacLellanWRFonarowGC2004Statin therapy is associated with improved survival in ischemic and non-ischemic heart failureJ Am Coll Cardiol43642814975476
   PubMed Web of Science ®Google Scholar
• JonesPHDavidsonMHSteinEA2003Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial)Am J Cardiol921526012860216
   PubMed Web of Science ®Google Scholar
• LaRosaJCGrundySMWatersDD2005Intensive lipid lowering with atorvastatin in patients with stable coronary diseaseN Eng J Med352142535
   PubMed Web of Science ®Google Scholar
• [LIPID] The LIPID Study Group2002Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-upLancet35913798711978335
   PubMed Web of Science ®Google Scholar
• [LIPID] The Long-Term Intervention With Pravastatin in Ischaemic Disease (LIPID) Study Group1998Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levelsN Engl J Med3391349579841303
   PubMed Web of Science ®Google Scholar
• LewisSJMoyeLASacksFM1998Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) TrialAnn Intern Med12968199841599
   PubMed Web of Science ®Google Scholar
• MiettinenTAPyoralaKOlssonAG1997Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris. Findings from the Scandinavian Simvastatin Survival Study (4S)Circulation964211189416884
   PubMed Web of Science ®Google Scholar
• MohlerERIIIHiattWRCreagerMAfor the Study Investigators2003Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial diseaseCirculation1081481612952839
   PubMed Web of Science ®Google Scholar
• MondilloSBalloPBarbatiR2003Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular diseaseAm J Med1143596412714124
   PubMed Web of Science ®Google Scholar
• [NCEP] Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults2001Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA28524869711368702
   PubMed Web of Science ®Google Scholar
• NissenSENichollsSJSitahiI2006Effect of very high-intensity statin therapy on regression of coronary atherosclerosis. The ASTEROID trialJAMA29515566516533939
   PubMed Web of Science ®Google Scholar
• NissenSETuzcuEMSchoenhagenP2004Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. A randomized controlled trialJAMA29110718014996776
   PubMed Web of Science ®Google Scholar
• NovaroGMTiongIYPearceGL2001Effect of hydroxymethyglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosisCirculation1042205911684632
   PubMed Web of Science ®Google Scholar
• PedersenTRKjekshusJPyoralaK1998Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S)Am J Cardiol8133369468077
   PubMed Web of Science ®Google Scholar
• PedersenTRWilhelmsenLFaergemanO2000Follow-up study of patients randomized in the Scandinavian Simvastatin Survival Study (4S) of cholesterol loweringAm J Cardiol862576210922429
   PubMed Web of Science ®Google Scholar
• PrueksaritanontTTangCQiuY2002Effects of fibrates on metabolism of statins in human hepatocytesDrug Metab Dispos301280712386136
   PubMed Web of Science ®Google Scholar
• SacksFMPfefferMAMoyeLA1996The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levelsN Engl J Med335100198801446
   PubMed Web of Science ®Google Scholar
• [SSS] Scandinavian Simvastatin Survival Study Group1994Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)Lancet344138397968073
   PubMed Web of Science ®Google Scholar
• SchwartzGGOlssonAGEzekowitzMD2001Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: a randomized controlled trialJAMA28517111811277825
   PubMed Web of Science ®Google Scholar
• SeverPSDahlofBPoulterNR2003Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialLancet36111495812686036
   PubMed Web of Science ®Google Scholar
• ShepherdJBlauwGJMurphyMB2002Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialLancet36016233012457784
   PubMed Web of Science ®Google Scholar